Pancreatic neuroendocrine tumor staging: Difference between revisions
Shanshan Cen (talk | contribs) (Created page with "__NOTOC__ {{Pancreatic neuroendocrine tumor}} {{CMG}} ==Staging== The 2010 WHO classification of tumors of the digestive system grades all the neuroendocrine tumors int...") |
Ahmed Younes (talk | contribs) |
||
Line 7: | Line 7: | ||
==Staging== | ==Staging== | ||
The 2010 WHO classification of tumors of the digestive system grades all the [[neuroendocrine tumor]]s into three categories, based on their degree of [[Grading (tumors)|cellular differentiation]] (from well-differentiated "NET G1" through to poorly-differentiated "NET G3"). The NCCN recommends use of the same AJCC-UICC staging system as pancreatic adenocarcinoma. Using this scheme, the stage by stage outcomes for PanNETs are dissimilar to pancreatic exocrine cancers.<ref name="NCI_FIG1">National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality [http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/HealthProfessional/page1]</ref> A different TNM system for PanNETs has been proposed by The European Neuroendocrine Tumor Society. | The 2010 WHO classification of tumors of the digestive system grades all the [[neuroendocrine tumor]]s into three categories, based on their degree of [[Grading (tumors)|cellular differentiation]] (from well-differentiated "NET G1" through to poorly-differentiated "NET G3"). The NCCN recommends use of the same AJCC-UICC staging system as pancreatic adenocarcinoma. Using this scheme, the stage by stage outcomes for PanNETs are dissimilar to pancreatic exocrine cancers.<ref name="NCI_FIG1">National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality [http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/HealthProfessional/page1]</ref> A different TNM system for PanNETs has been proposed by The European Neuroendocrine Tumor Society. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 17:03, 23 May 2019
Pancreatic neuroendocrine tumor Microchapters |
Differentiating Pancreatic neuroendocrine tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Pancreatic neuroendocrine tumor staging On the Web |
American Roentgen Ray Society Images of Pancreatic neuroendocrine tumor staging |
Directions to Hospitals Treating Pancreatic neuroendocrine tumor |
Risk calculators and risk factors for Pancreatic neuroendocrine tumor staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Staging
The 2010 WHO classification of tumors of the digestive system grades all the neuroendocrine tumors into three categories, based on their degree of cellular differentiation (from well-differentiated "NET G1" through to poorly-differentiated "NET G3"). The NCCN recommends use of the same AJCC-UICC staging system as pancreatic adenocarcinoma. Using this scheme, the stage by stage outcomes for PanNETs are dissimilar to pancreatic exocrine cancers.[1] A different TNM system for PanNETs has been proposed by The European Neuroendocrine Tumor Society.